MedTrace Logo

Nexplanon Observational Risk Assessment Study (NORA)

NCT01473641 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7364

Last updated 2019-11-07

No results posted yet for this study

Summary

This study characterises the frequency of specific insertion-, localization- and removal-related events and clinically significant consequences thereof among Nexplanon users in the US during routine clinical use.

Conditions

  • Contraception

Sponsors & Collaborators

Principal Investigators

  • Klaas Heinemann, MD, MBA, PhD · Center for Epidemiology and Health Research, Berlin, Germany

Eligibility

Min Age
12 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01473641 on ClinicalTrials.gov